Analysis of non-canonical functions of microRNAs
microRNA的非典型功能分析
基本信息
- 批准号:10563155
- 负责人:
- 金额:$ 34.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-03-01 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAffectAnemiaBindingBiochemicalBiogenesisBioinformaticsBiological AssayBiological ModelsBloodCRISPR/Cas technologyCatalytic DomainCell ReprogrammingCellsDataDevelopmentDiseaseDoseEmbryoEmbryonic DevelopmentEnsureErythrocytesErythroidErythropoiesisFamilyFishesFlow CytometryFutureGene Expression ProfilingGenesGeneticGenetic ModelsGenomic approachGoalsHematopoieticHomeostasisHumanMediatingMessenger RNAMicroRNAsMolecularPathway interactionsProcessProductionRepressionRibonuclease IIIRoleRouteSeriesSmall RNASpecific qualifier valueStructureSystemTestingTherapeutic InterventionTimeTranscriptUntranslated RNAWorkZebrafishaptamerembryo tissueexperienceexperimental studygene repressiongenetic approachimprovedinduced pluripotent stem cellinhibitorinsightmutantnoveloverexpressionposttranscriptionalprogenitorprogramsstemstem cell differentiationtranscriptome sequencing
项目摘要
PROJECT SUMMARY: “Analysis of non-canonical functions of microRNAs”
Commitment to cell-fate decisions is fundamental for proper embryonic development and tissue homeostasis.
microRNAs, a family of small non-coding RNAs, are among the factors that actively participate in many
differentiation processes. Indeed, the last step of differentiation during erythropoiesis is in part governed by miR-
451 and its demise leads to severe anemia. Surprisingly, miR-451 is the only known microRNA whose processing
is Dicer-independent but Ago2-dependent. Paradoxically, Dicer is still expressed in erythrocytes, raising the
question of what possible advantage represents for erythropoiesis to process miR-451 through a non-canonical
pathway. The goal of this project is to uncover by which mechanisms the non-canonical processing of miR-451
becomes indispensable for erythrocyte differentiation. We hypothesize that this alternative processing pathway
favors miR-451 production while actively suppressing the Dicer-dependent processing of other microRNAs,
thereby ensuring an efficient and precise mechanism to control terminal erythrocyte differentiation.
Recent work from our lab and others indicate that miR-451 comprises up to 60% of the microRNA content of
maturing erythrocytes, while miR-144 that is co-expressed as a cluster with miR-451 and processed by Dicer
only accounts for 1.5%. These results are in striking contrast with our preliminary data that shows that Ago2-
dependent processing is not as efficient as Dicer-mediated biogenesis. Surprisingly, our most recent data
suggests that pre-miR-451 represses canonical microRNA biogenesis and that Dicer is a target of miR-144.
Leveraging all these data, the current proposal examines the hypothesis that miR-451 has a second activity,
unrelated to its sequence but dependent on its structural features as a competitive inhibitor of Dicer.
Three highly integrated but not interdependent Aims will address the above hypothesis using a set of
reprogrammed pre-miR-451 hairpins to i) determine the biochemical features of miR-451/Dicer interaction and
their role on canonical miRNA biogenesis, ii) uncover the role of miR-144 in miR-451 processing and iii) identify
the erythropoietic processes that most depend on the Ago2-mediated biogenesis of miR-451. Using zebrafish
and human iPSC as a model system, the current proposal uses novel genetic and molecular approaches to
mechanistically probe the interplay of canonical and non-canonical microRNA processing pathways during
erythropoiesis. In doing so, it will uncover mechanisms with the potential to instruct future improvements in blood
production form iPSC and therapeutic interventions on anemia. The novelty of the proposal is also driven by an
interdisciplinary team that combines experience in microRNAs, zebrafish, bioinformatics and iPSC
differentiation. The successful completion of this project will transform our understanding of how microRNAs
regulate cell fate and provide invaluable insights to improve iPSC reprogramming to erythrocytes.
项目总结:“microRNA的非典型功能分析”
对细胞命运决定的承诺是正确的胚胎发育和组织稳态的基础。
microRNA是一个小的非编码RNA家族,是积极参与许多细胞凋亡的因素之一。
分化过程。事实上,在红细胞生成过程中分化的最后一步部分是由miR-21调控的。
451和它的死亡导致严重贫血。令人惊讶的是,miR-451是唯一已知的微RNA,
是Dicer独立的但Ago 2依赖的。奇怪的是,Dicer仍然在红细胞中表达,从而提高了红细胞中Dicer的表达。
问题是红细胞生成通过非典型的
通路该项目的目标是揭示miR-451的非经典加工机制,
成为红细胞分化不可或缺的条件。我们假设这种替代加工途径
有利于miR-451的产生,同时积极抑制其他microRNA的Dicer依赖性加工,
从而确保控制终末红细胞分化的有效和精确的机制。
我们实验室和其他实验室的最新工作表明,miR-451包含高达60%的microRNA含量,
成熟红细胞,而与miR-451共表达为簇并由Dicer加工的miR-144
只占百分之一点五。这些结果与我们的初步数据形成鲜明对比,这些数据表明Ago 2-
依赖性加工不如Dicer介导的生物发生有效。令人惊讶的是,我们最新的数据
提示pre-miR-451抑制典型microRNA生物发生,Dicer是miR-144的靶点。
利用所有这些数据,目前的提议检验了miR-451具有第二活性的假设,
与其序列无关,但依赖于其作为Dicer竞争性抑制剂的结构特征。
三个高度综合但不相互依赖的目标将使用一套
重编程的前-miR-451发夹以i)确定miR-451/Dicer相互作用的生物化学特征,和
它们在典型miRNA生物发生中的作用,ii)揭示miR-144在miR-451加工中的作用,iii)鉴定
最依赖于Ago 2介导的miR-451生物合成的红细胞生成过程。利用斑马鱼
和人类iPSC作为模型系统,目前的建议使用新的遗传和分子方法,
机械地探测典型和非典型microRNA加工途径的相互作用,
红细胞生成在这样做的过程中,它将揭示具有指导未来血液改善的潜力的机制。
生产形式iPSC和贫血的治疗干预。该提案的新奇也受到一个
跨学科团队,结合了microRNA、斑马鱼、生物信息学和iPSC方面的经验
分化该项目的成功完成将改变我们对microRNA如何
调节细胞命运,并提供宝贵的见解,以改善iPSC重编程为红细胞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Cifuentes其他文献
Daniel Cifuentes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Cifuentes', 18)}}的其他基金
Analysis of non-canonical functions of microRNAs
microRNA的非典型功能分析
- 批准号:
10799098 - 财政年份:2023
- 资助金额:
$ 34.41万 - 项目类别:
Developing a high-throughput method to validate microRNA biogenesis in vivo.
开发一种高通量方法来验证 microRNA 体内生物发生。
- 批准号:
10210415 - 财政年份:2020
- 资助金额:
$ 34.41万 - 项目类别:
Developing a high-throughput method to validate microRNA biogenesis in vivo.
开发一种高通量方法来验证 microRNA 体内生物发生。
- 批准号:
10043005 - 财政年份:2020
- 资助金额:
$ 34.41万 - 项目类别:
Analysis of non-canonical functions of microRNAs
microRNA的非典型功能分析
- 批准号:
10582107 - 财政年份:2019
- 资助金额:
$ 34.41万 - 项目类别:
Analysis of non-canonical functions of microRNAs
microRNA的非典型功能分析
- 批准号:
10358511 - 财政年份:2019
- 资助金额:
$ 34.41万 - 项目类别:
Analysis of the Molecular Machinery of microRNA-processing pathways
microRNA 加工途径的分子机械分析
- 批准号:
9257451 - 财政年份:2016
- 资助金额:
$ 34.41万 - 项目类别:
Analysis of the Molecular Machinery of microRNA-processing pathways
microRNA 加工途径的分子机械分析
- 批准号:
8442460 - 财政年份:2013
- 资助金额:
$ 34.41万 - 项目类别:
Analysis of the Molecular Machinery of microRNA-processing pathways
microRNA 加工途径的分子机械分析
- 批准号:
8698432 - 财政年份:2013
- 资助金额:
$ 34.41万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
Research Grant